BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19334050)

  • 1. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
    Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
    J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
    Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
    Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer.
    Riley CJ; Engelhardt KP; Saldanha JW; Qi W; Cooke LS; Zhu Y; Narayan ST; Shakalya K; Croce KD; Georgiev IG; Nagle RB; Garewal H; Von Hoff DD; Mahadevan D
    Cancer Res; 2009 Mar; 69(5):1933-40. PubMed ID: 19244123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
    Duxbury MS; Matros E; Clancy T; Bailey G; Doff M; Zinner MJ; Ashley SW; Maitra A; Redston M; Whang EE
    Ann Surg; 2005 Mar; 241(3):491-6. PubMed ID: 15729073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
    Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of CEACAM6 using antibody probes of different sizes.
    Niu G; Murad YM; Gao H; Hu S; Guo N; Jacobson O; Nguyen TD; Zhang J; Chen X
    J Control Release; 2012 Jul; 161(1):18-24. PubMed ID: 22568933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells.
    Cheng TM; Murad YM; Chang CC; Yang MC; Baral TN; Cowan A; Tseng SH; Wong A; Mackenzie R; Shieh DB; Zhang J
    Eur J Cancer; 2014 Mar; 50(4):713-21. PubMed ID: 22918079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
    Duxbury MS; Ito H; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
    Duxbury MS; Ito H; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity.
    Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG
    Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE
    Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
    Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
    Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6.
    Han HS; Son SM; Yun J; Jo YN; Lee OJ
    FEBS Lett; 2014 Oct; 588(20):3744-50. PubMed ID: 25171863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma.
    Yan L; Wang Y; Wang ZZ; Rong YT; Chen LL; Li Q; Liu T; Chen YH; Li YD; Huang ZH; Peng J
    Oncol Rep; 2016 Jan; 35(1):418-26. PubMed ID: 26497080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer.
    Gebauer F; Wicklein D; Horst J; Sundermann P; Maar H; Streichert T; Tachezy M; Izbicki JR; Bockhorn M; Schumacher U
    PLoS One; 2014; 9(11):e113023. PubMed ID: 25409014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of CEACAM6 and FOXP3 on tumor infiltrating lymphocytes and prognosis in patients with pancreatic cancer].
    Zhang K; Liu Y; Jin C; Gu D; Xia T; Ye J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1103-7. PubMed ID: 26271985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma.
    Kong Y; Xie F; Zhang Z; Wang S; Zhang Y; Di Y; Zhou Z; Jiang D; Li J; Huang Q; Wang J; Li X; Pan Z; Ni R; Guan Y
    Eur Radiol; 2023 Oct; 33(10):7077-7088. PubMed ID: 37166496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells.
    Kanderová V; Hrusák O; Kalina T
    Exp Hematol; 2010 Aug; 38(8):653-660.e1. PubMed ID: 20380867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.